LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression by Blagden, S, Bushell, M, Willis, A, Mura, M, Hopkins, T, Michael, T, Abd-Latip, N, Curry, E, Weir, J, Aboagye, E, Sturge, J, Jameson, C, Mauri, F

Dose-finding quantitative 18F-FDG PET imaging study with the oral pan-AKT inhibitor GSK2141795 in patients with gynecological malignancies by Gungor, H, Saleem, A, Babar, S, Dina, R, El-Bahrawy, M, Curry, E, Rama, N, Chen, M, Pickford, E, Agarwal, R, Blagden, S, Carme, S, Salinas, C, Madison, S, Krachey, E, Santiago-Walker, A, Smith, D, Morris, S, Stronach, E, Gabra, H